510 related articles for article (PubMed ID: 14990395)
21. The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations.
Kodric M; Garuti G; Colomban M; Russi B; Porta RD; Lusuardi M; Confalonieri M
Respirology; 2009 Apr; 14(3):424-8. PubMed ID: 19192230
[TBL] [Abstract][Full Text] [Related]
22. Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1.
Zuwallack RL; Nici L
COPD; 2012 Dec; 9(6):637-48. PubMed ID: 22958136
[TBL] [Abstract][Full Text] [Related]
23. COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study.
Miravitlles M; Izquierdo I; Herrejón A; Torres JV; Baró E; Borja J;
Respir Med; 2011 May; 105(5):740-7. PubMed ID: 21227672
[TBL] [Abstract][Full Text] [Related]
24. Acute exacerbations of COPD: delay in presentation and the risk of hospitalization.
Chandra D; Tsai CL; Camargo CA
COPD; 2009 Apr; 6(2):95-103. PubMed ID: 19378222
[TBL] [Abstract][Full Text] [Related]
25. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
[TBL] [Abstract][Full Text] [Related]
26. Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?
Goossens LM; Nivens MC; Sachs P; Monz BU; Rutten-van Mölken MP
Respir Med; 2011 Aug; 105(8):1195-202. PubMed ID: 21439807
[TBL] [Abstract][Full Text] [Related]
27. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Bhowmik A; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 2000 May; 161(5):1608-13. PubMed ID: 10806163
[TBL] [Abstract][Full Text] [Related]
28. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
Soler-Cataluña JJ; Martínez-García MA; Sánchez LS; Tordera MP; Sánchez PR
Respir Med; 2009 May; 103(5):692-9. PubMed ID: 19131231
[TBL] [Abstract][Full Text] [Related]
29. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations.
Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Platt RW; Wang C; Bourbeau J
Am J Respir Crit Care Med; 2008 Nov; 178(9):913-20. PubMed ID: 18755925
[TBL] [Abstract][Full Text] [Related]
30. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial.
Trappenburg JC; Monninkhof EM; Bourbeau J; Troosters T; Schrijvers AJ; Verheij TJ; Lammers JW
Thorax; 2011 Nov; 66(11):977-84. PubMed ID: 21785156
[TBL] [Abstract][Full Text] [Related]
31. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.
Aaron SD; Vandemheen KL; Hebert P; Dales R; Stiell IG; Ahuja J; Dickinson G; Brison R; Rowe BH; Dreyer J; Yetisir E; Cass D; Wells G
N Engl J Med; 2003 Jun; 348(26):2618-25. PubMed ID: 12826636
[TBL] [Abstract][Full Text] [Related]
32. Depression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary disease.
Ito K; Kawayama T; Shoji Y; Fukushima N; Matsunaga K; Edakuni N; Uchimura N; Hoshino T
Respirology; 2012 Aug; 17(6):940-9. PubMed ID: 22564039
[TBL] [Abstract][Full Text] [Related]
33. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year.
Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Wang C; Bourbeau J
Eur Respir J; 2010 May; 35(5):1022-30. PubMed ID: 19897555
[TBL] [Abstract][Full Text] [Related]
34. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
Fromer L; Barnes T; Garvey C; Ortiz G; Saver DF; Yawn B
Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
[TBL] [Abstract][Full Text] [Related]
35. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.
Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA
Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174
[TBL] [Abstract][Full Text] [Related]
36. The impact of chronic obstructive pulmonary disease exacerbation on pulmonary rehabilitation participation and functional outcomes.
Steele BG; Belza B; Cain K; Coppersmith J; Howard J; Lakshminarayan S; Haselkorn J
J Cardiopulm Rehabil Prev; 2010; 30(1):53-60. PubMed ID: 20068424
[TBL] [Abstract][Full Text] [Related]
37. The health, activity, dyspnea, obstruction, age, and hospitalization: prognostic score for stable COPD patients.
Esteban C; Quintana JM; Aburto M; Moraza J; Arostegui I; España PP; Aizpiri S; Capelastegui A
Respir Med; 2011 Nov; 105(11):1662-70. PubMed ID: 21703842
[TBL] [Abstract][Full Text] [Related]
38. Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary.
Leidy NK; Wilcox TK; Jones PW; Roberts L; Powers JH; Sethi S;
Am J Respir Crit Care Med; 2011 Feb; 183(3):323-9. PubMed ID: 20813886
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.
Fukuchi Y; Fernandez L; Kuo HP; Mahayiddin A; Celli B; Decramer M; Kesten S; Liu D; Tashkin D
Respirology; 2011 Jul; 16(5):825-35. PubMed ID: 21539680
[TBL] [Abstract][Full Text] [Related]
40. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
Suh DC; Lau H; La HO; Choi IS; Geba GP
Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]